Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. | iScience | 2023 | 37593458 | PubTator, text mining | PubMed |
| Five new species of Gloeandromyces (Fungi, Laboulbeniales) from tropical American bat flies (Diptera, Streblidae), revealed by morphology and phylogenetic reconstruction. | Mycologia | 2023 | 37589548 | PubTator, text mining | PubMed |
| Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283 [Retraction]. | Onco Targets Ther | 2023 | 37587912 | PubTator, text mining | PubMed |
| Heteroverticillium phytelephatis gen. et sp. nov. intercepted from nuts of Phytelephas macrocarpa, with an updated phylogenetic assessment of Nectriaceae. | Mycology | 2023 | 37583458 | PubTator, text mining | PubMed |
| CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties. | Signal Transduct Target Ther | 2023 | 37582812 | PubTator, text mining | PubMed |
| New insights into the important roles of phase seperation in the targeted therapy of lung cancer. | Cell Biosci | 2023 | 37580790 | PubTator, text mining | PubMed |
| Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1. | J Virol | 2023 | 37578237 | PubTator, text mining | PubMed |
| A fibroblast-dependent TGFβ1/sFRP2 noncanonical Wnt signaling axis underlies epithelial metaplasia in idiopathic pulmonary fibrosis. | bioRxiv | 2023 | 37577522 | PubTator, text mining | PubMed |
| CENPA-driven STMN1 Transcription Inhibits Ferroptosis in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37577230 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Distinct response of adipocyte progenitors to glucocorticoids determines visceral obesity via the TEAD1-miR-27b-PRDM16 axis. | Obesity (Silver Spring) | 2023 | 37574723 | PubTator, text mining | PubMed |
| The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ. | Hum Mol Genet | 2023 | 37565816 | PubTator, text mining | PubMed |
| Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma. | Comput Struct Biotechnol J | 2023 | 37564101 | PubTator, text mining | PubMed |
| Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape. | Nat Commun | 2023 | 37563143 | PubTator, text mining | PubMed |
| TT3, a More Practical Indicator for Evaluating the Relationship Between Sarcopenia and Thyroid Hormone in the Euthyroid Elderly Compared with FT3. | Clin Interv Aging | 2023 | 37560750 | PubTator, text mining | PubMed |
| Two new lanostanoid glycosides isolated from a Kenyan polypore Fomitopsis carnea. | Beilstein J Org Chem | 2023 | 37560136 | PubTator, text mining | PubMed |
| Circular RNA circTIE1 drives proliferation, migration, and invasion of glioma cells through regulating miR-1286/TEAD1 axis. | Am J Cancer Res | 2023 | 37560005 | PubTator, text mining | PubMed |
| miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets. | J Cell Mol Med | 2023 | 37555915 | PubTator, text mining | PubMed |
| BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. | Theranostics | 2023 | 37554265 | PubTator, text mining | PubMed |
| P4HA2-induced prolyl hydroxylation of YAP1 restricts vascular smooth muscle cell proliferation and neointima formation. | Life Sci | 2023 | 37549826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=21